Title | Management of thymoma-associated pure red cell aplasia: A novel use of blood substitute HBOC-201 in a Jehovah's Witness. |
Publication Type | Journal Article |
Year of Publication | 2020 |
Authors | Rubinstein MM, Goss C, Avecilla ST, Dubé GP, Riely GJ, Mones JV |
Journal | Clin Case Rep |
Volume | 8 |
Issue | 2 |
Pagination | 289-292 |
Date Published | 2020 Feb |
ISSN | 2050-0904 |
Abstract | Pure red cell aplasia (PRCA) is a rare paraneoplastic syndrome occasionally associated with thymomas. Here, we report on the first ever use of a bovine hemoglobin-based oxygen carrier, HBOC-201 (HbO2 Therapeutics LLC; Hemopure, Waltham, MA) for the supportive management of pure red cell aplasia in a Jehovah Witness patient. |
DOI | 10.1002/ccr3.2626 |
Alternate Journal | Clin Case Rep |
PubMed ID | 32128175 |
PubMed Central ID | PMC7044386 |
Grant List | P30 CA008748 / CA / NCI NIH HHS / United States |
Related Faculty:
Cheryl Goss, M.D.